http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108785316-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108785316-B |
| titleOfInvention | Use of Xiangjiapi C21 steroids in the preparation of IDO inhibitors |
| abstract | The invention belongs to the field of medicines or health-care products, in particular to the use of fragrant peel C21 steroids in the preparation of IDO inhibitors. In the present invention, it is found through research that gallicoside C, gallicoside D, gallicoside O, gallicoside P, gallicoside Q, gallicoside R, gallicoside S, gallicoside M and gallicoside N The inhibitory activity on intracellular IDO is better than that of the positive control drug 1-methyltryptophan (1-MT) on intracellular IDO, has significant inhibitory activity of IDO, and can be used for the treatment of cancer, Alzheimer's disease Zheimer's disease, autoimmune disease, ankylosing spondylitis, bacterial infection, cataract, mood disorder, depression or anxiety. |
| priorityDate | 2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.